Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Radiation × Clear all

Sponsor

Conditions

Glioblastoma 21 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 13 Rectal Neoplasms 11 Prostatic Neoplasms 11 Gliosarcoma 11 Esophageal Neoplasms 9 Brain Neoplasms 9 Uterine Cervical Neoplasms 8 Lung Neoplasms 8 Adenocarcinoma Of Esophagus 8 Neoplasms 7 Head and Neck Neoplasms 7 Pancreatic Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Squamous Cell 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Glioma 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Endometrial Neoplasms 4 Burkitt Lymphoma 4 Breast Neoplasms, Male 4 Rhabdomyosarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡